Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyridoxine in atopic dermatitis

D C Mabin1, S Hollis, J Lockwood

  • 1Department of Child Health, University of Manchester, Booth Hall Children's Hospital, Blackley, U.K.

The British Journal of Dermatology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intradural extramedullary metastatic melanoma: A case report and review of the literature.

Clinical neurology and neurosurgery·2020
Same author

Case series of non-freezing cold injury: the modern clinical syndrome.

BMJ military health·2019
Same author

Case series of non-freezing cold injury: epidemiology and risk factors.

Journal of the Royal Army Medical Corps·2018
Same author

Bogus Allergy Treatment.

Bristol medico-chirurgical journal (1963)·2017
Same author

Correspondence.

Bristol medico-chirurgical journal (1963)·2017
Same author

Sci-Fri AM: Imaging - 09: Serial estimation of cross-talk for correction in dual-isotope imaging with dynamic tracers.

Medical physics·2017

Pyridoxine hydrochloride (vitamin B6) supplementation did not show significant benefits for children with atopic dermatitis. This randomized trial found no improvement in clinical severity or symptoms compared to placebo.

Area of Science:

  • Dermatology
  • Clinical Nutrition
  • Pediatrics

Background:

  • Previous research suggested potential benefits of pyridoxine hydrochloride for atopic dermatitis.
  • Atopic dermatitis is a common inflammatory skin condition in children.
  • The efficacy of pyridoxine supplementation in pediatric atopic dermatitis requires further investigation.

Purpose of the Study:

  • To evaluate the clinical effectiveness of pyridoxine hydrochloride in children with moderate to severe atopic dermatitis.
  • To assess the impact of pyridoxine supplementation on disease activity and symptoms.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted.
  • Forty-eight children with atopic dermatitis were enrolled.
  • Participants received either pyridoxine hydrochloride (50 mg daily) or placebo for 4 weeks, with outcomes assessed via clinical severity and symptom scores.

Related Experiment Videos

Main Results:

  • No statistically significant differences in clinical severity scores were observed between the pyridoxine hydrochloride and placebo groups.
  • Parent-reported symptom scores for itch and sleep disturbance also showed no significant improvement with pyridoxine supplementation.
  • The study did not demonstrate a clinical benefit of pyridoxine hydrochloride in this pediatric cohort.

Conclusions:

  • Pyridoxine hydrochloride supplementation at 50 mg daily for 4 weeks did not prove effective in treating moderate to severe atopic dermatitis in children.
  • Further research may be needed to explore alternative dosages or specific subgroups, but current evidence does not support its use.
  • This study failed to replicate previous findings of benefit in a pediatric population.